上海醫藥(601607.SH):擬公開發行面值總額不超50億元公司債券
格隆匯3月30日丨上海醫藥(601607.SH)公佈,為順應公司戰略規劃以及經營業務發展需要,拓寬公司融資渠道,優化現有融資結構,合理控制公司整體融資成本,以更好的發揮財務槓桿效應,公司擬發行公司債券。
此次擬發行公司債券面值100元,按面值平價發行。此次債券面值總額不超過人民幣50億元(含50億元),既可一次性發行,也可以採用分期發行的方式,具體發行規模提請股東大會授權董事會執行委員會根據國家法律、法規及證券監督管理部門的有關規定,結合公司資金需求情況和發行時市場情況,在上述範圍內確定。
此次債券在獲得中國證監會註冊後,既可採取一次性發行,也可以採用分期發行的方式在中國境內公開發行。具體發行方式提請股東大會授權董事會執行委員會根據公司資金需求情況和發行時市場情況,在上述範圍內確定。
債券發行所募集資金扣除發行費用後擬用於償還公司及子公司有息債務、補充流動資金或符合法律、法規規定的其他用途。提請股東大會授權董事會執行委員會根據公司財務狀況及資金需求等實際情況決定在前述範圍內確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.